Introduction: There are few published studies on predictors of response to treatment with sofosbuvir and simeprevir in HCV patients.
Objective: The objective of the study was to analyse possible predictors of response to simeprevir (SMV) and sofosbuvir (SOF) in patients infected with hepatitis C genotypes 1 or 4.
Patients And Methods: Prospective observational cohort study in 12 hospitals.